Genetic diagnosis of Mendelian disorders via RNA sequencing.
Genetic diagnosis of Mendelian disorders via RNA sequencing.
复制标题
DOI:
10.1038/ncomms15824
复制
发表时间:
2017-06-12
影响因子:
16.6
通讯作者:
Prokisch H
中科院分区:
文献类型:
--
作者:
Kremer LS;Bader DM;Mertes C;Kopajtich R;Pichler G;Iuso A;Haack TB;Graf E;Schwarzmayr T;Terrile C;Koňaříková E;Repp B;Kastenmüller G;Adamski J;Lichtner P;Leonhardt C;Funalot B;Donati A;Tiranti V;Lombes A;Jardel C;Gläser D;Taylor RW;Ghezzi D;Mayr JA;Rötig A;Freisinger P;Distelmaier F;Strom TM;Meitinger T;Gagneur J;Prokisch H
Across a variety of Mendelian disorders, ∼50–75% of patients do not receive a genetic diagnosis by exome sequencing indicating disease-causing variants in non-coding regions. Although genome sequencing in principle reveals all genetic variants, their sizeable number and poorer annotation make prioritization challenging. Here, we demonstrate the power of transcriptome sequencing to molecularly diagnose 10% (5 of 48) of mitochondriopathy patients and identify candidate genes for the remainder. We find a median of one aberrantly expressed gene, five aberrant splicing events and six mono-allelically expressed rare variants in patient-derived fibroblasts and establish disease-causing roles for each kind. Private exons often arise from cryptic splice sites providing an important clue for variant prioritization. One such event is found in the complex I assembly factor TIMMDC1 establishing a novel disease-associated gene. In conclusion, our study expands the diagnostic tools for detecting non-exonic variants and provides examples of intronic loss-of-function variants with pathological relevance. Genome sequencing alone fails to provide a genetic diagnosis for many Mendelian disorder patients. Here, the authors utilize RNA sequencing to complement genotyping of patients with a rare mitochondrial disease by detecting aberrant RNA expression, splicing and allele-specific expression.